Calm, accurate health journalism. Weekly explainers on nutrition, fitness, sleep, and the science of feeling better.

A groundbreaking study reveals that consuming two to three cups of coffee daily significantly reduces the risk of dementia before…

The FDA granted a groundbreaking Breakthrough Device Designation to Valar Labs’ Vesta, an AI tool that revolutionizes bladder cancer prognosis…

Efgartigimod IV, poised for FDA review, offers a promising new option for myasthenia gravis patients, marking a shift toward targeted…

The DO-HEALTH trial reveals that a combination of omega-3, vitamin D, and strength training slows biological aging in older adults,…

Eli Lilly’s Foundayo, the first GLP-1 oral pill without intake restrictions, heralds a new era in weight-loss pharmacotherapy.

A groundbreaking phase 1 clinical trial of a CD40 agonist cancer therapy has demonstrated a 50% response rate, heralding a…